Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA

被引：0

作者：

D Călugăru

M Călugăru

机构：

[1] University of Medicine,Department of Ophthalmology

来源：

Eye | 2015年 / 29卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1113 / 1113

共 50 条

[21] Comparing Cytokine Kinetics between Ranibizumab and Aflibercept in Central Retinal Vein Occlusion with Macular Edema
Kotake, Osamu
Noma, Hidetaka
Yasuda, Kanako
Motohashi, Ryosuke
Goto, Hiroshi
Shimura, Masahiko
OPHTHALMIC RESEARCH, 2019, 61 (04) : 210 - 217
[22] Aflibercept versus bevacizumab and/or ranibizumab for recurrent macular edema secondary to central retinal vein occlusion
Dedania, Vaidehi
Ozgonul, Cem
Besirli, Cagri G.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[23] Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion
Ozgonul, Cem
Dedania, Vaidehi S.
Besirli, Cagri G.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (04) : 340 - 345
[24] Retinal vascular oximetry during ranibizumab treatment of central retinal vein occlusion
Traustason, Sindri
la Cour, Morten
Larsen, Michael
BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (09) : 1208 - 1211
[25] THREE YEAR TREATMENT PATTERNS OF RANIBIZUMAB AND AFLIBERCEPT FOR THE MANAGEMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN ROUTINE CLINICAL PRACTICE IN THE USA
Leteneux, C.
Milnes, F.
Skelly, A.
Bezlyak, V
Paschen, E.
Sagkriotis, A.
VALUE IN HEALTH, 2016, 19 (07) : A574 - A574
[26] Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'
Williams, M. A.
Shute, C.
Wright, S.
EYE, 2018, 32 (02) : 468 - 469
[27] Sir, Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
Calugaru, D.
Calugaru, M.
EYE, 2017, 31 (07) : 1112 - 1113
[28] Comments on ‘Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA’
M A Williams
C Shute
S Wright
Eye, 2018, 32 : 468 - 469
[29] Real world clinical audit of aflibercept and ranibizumab use in the management of macular oedema secondary to central retinal vein occlusion
Elatfy, Mohammed
Than, Jonathan
Palexas, George
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[30] Comment on: 'Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab'
Calugaru, D.
Calugaru, M.
EYE, 2016, 30 (05) : 766 - 766

← 1 2 3 4 5 →